Pharmacokinetics and molecular detoxication.

This paper presents a comprehensive overview of the pharmacokinetic parameters used from in vivo and in vitro studies that are important in order to understand the major conceptual approaches of toxicokinetics and the disposition of environmental chemicals. In vitro biochemical information concerning the detoxication of environmental chemicals is also presented. The discussion leads to a more complete appreciation for the use of in vitro measurements for in vivo correlations. The concept of interspecies scaling in the interpolation and extrapolation of fundamental biochemical metabolic processes is illustrated with a number of examples. Additional examples of in vitro-in vivo correlations are presented in the evaluation of the impact of chemical exposure to humans. Finally, several important metabolic detoxication enzymes are presented, including the mammalian microsomal cytochrome P450 and flavin-containing monooxygenases as well as carboxylesterases and glucuronosyltransferases, to provide insight into the processes of chemical detoxication in mammalian tissue and blood. Because interspecies scaling and the pharmacokinetics of chemical disposition have already shown their usefulness in understanding some examples of chemical disposition, our summary focuses on showing the usefulness of the pharmacokinetic equations and providing confidence in using the approach for in vitro-in vivo correlations. Ultimately, the presentation may provide the reader with a conceptual framework for future evaluation of the human health risks associated with environmental toxicants.

[1]  J. Sommadossi,et al.  Modulation of 3'-azido-3'-deoxythymidine catabolism by probenecid and acetaminophen in freshly isolated rat hepatocytes. , 1991, Biochemical pharmacology.

[2]  S. Wrighton,et al.  In vitro-in vivo correlations of human (S)-nicotine metabolism. , 1995, Biochemical pharmacology.

[3]  D. M. Soderlund,et al.  Structure-biodegradability relationships in pyrethroid insecticides , 1975, Archives of environmental contamination and toxicology.

[4]  A. Varki,et al.  A sialic acid-specific O-acetylesterase in human erythrocytes: possible identity with esterase D, the genetic marker of retinoblastomas and Wilson disease. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[5]  R. Gupta,et al.  Acute tabun toxicity; biochemical and histochemical consequences in brain and skeletal muscles of rat. , 1987, Toxicology.

[6]  C. Irving Influence of the aryl group on the reaction of glucuronides of N-arylacethydroxamic acids with polynucleotides. , 1977, Cancer research.

[7]  Y. Hatakeyama,et al.  Phenthoate metabolites in human poisoning. , 1994, Journal of toxicology. Clinical toxicology.

[8]  David G. Da Vila,et al.  The Etiology of Lung Cancer , 1993 .

[9]  M. Wayner,et al.  Effects of three reputed carboxylesterase inhibitors upon rat serum esterase activity , 1991, Neuroscience & Biobehavioral Reviews.

[10]  M. Jackson,et al.  Cloning and substrate specificity of a human phenol UDP-glucuronosyltransferase expressed in COS-7 cells. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[11]  J. Brockmöller,et al.  Assessment of Liver Metabolic Function , 1994, Clinical pharmacokinetics.

[12]  J. Mordenti,et al.  Man versus beast: pharmacokinetic scaling in mammals. , 1986, Journal of pharmaceutical sciences.

[13]  L. Benet,et al.  Noncompartmental determination of the steady-state volume of distribution. , 1979, Journal of pharmaceutical sciences.

[14]  W. Benedict,et al.  Regional assignment of genes for human esterase D and retinoblastoma to chromosome band 13q14. , 1980, Science.

[15]  B. Martin,et al.  Cloning and sequencing of a human liver carboxylesterase isoenzyme. , 1991, Life sciences.

[16]  K. Wakabayashi,et al.  Purification and characterization of esterases D-1 and D-2 from human erythrocytes. , 1988, Archives of biochemistry and biophysics.

[17]  H. Willard,et al.  Cloning of the esterase D gene: a polymorphic gene probe closely linked to the retinoblastoma locus on chromosome 13. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[18]  J. Radomski,et al.  N-Glucuronidation of N-hydroxy aromatic amines: a mechanism for their transport and bladder-specific carcinogenicity. , 1979, Toxicology and applied pharmacology.

[19]  J. Lewis,et al.  Comparative localization of carboxylesterase in F344 rat, Beagle dog, and human nasal tissue , 1994, The Anatomical record.

[20]  B B Brodie,et al.  Possible mechanism of liver necrosis caused by aromatic organic compounds. , 1971, Proceedings of the National Academy of Sciences of the United States of America.

[21]  R. Luders,et al.  Metabolism of tripelennamine in man. , 1976, Drug metabolism and disposition: the biological fate of chemicals.

[22]  M. Jackson,et al.  Cloning of a human liver microsomal UDP-glucuronosyltransferase cDNA. , 1987, The Biochemical journal.

[23]  B. Gallie,et al.  Re-evaluation of the sublocalization of esterase D and its relation to the retinoblastoma locus by in situ hybridization. , 1987, Cytogenetics and cell genetics.

[24]  W. Bosron,et al.  Human liver cocaine carboxylesterases. , 1997, NIDA research monograph.

[25]  G. Mulder,et al.  Cholestatic effect of harmol glucuronide in the rat. Prevention of harmol-induced cholestasis by increased formation of harmol sulfate. , 1982, Journal of Pharmacology and Experimental Therapeutics.

[26]  E. LaVoie,et al.  Short-term studies on the in vivo metabolism of N-oxides of nicotine in rats. , 1986, Journal of toxicology and environmental health.

[27]  H. Chapman,et al.  A serine esterase released by human alveolar macrophages is closely related to liver microsomal carboxylesterases. , 1991, The Journal of biological chemistry.

[28]  E. Ralston,et al.  Sequence of three bronze alleles of maize and correlation with the genetic fine structure. , 1988, Genetics.

[29]  C. King,et al.  Activation of the O-glucuronide of the carcinogen N-hydroxy-N-2-fluorenylacetamide by enzymatic deacetylation in vitro: formation of fluorenylamine-tRNA adducts. , 1976, Biochemical pharmacology.

[30]  S. Oka,et al.  A novel glucuronyltransferase in nervous system presumably associated with the biosynthesis of HNK-1 carbohydrate epitope on glycoproteins. , 1992, The Journal of biological chemistry.

[31]  R. Thurman,et al.  The liver plays a central role in the mechanism of chemical carcinogenesis due to polycyclic aromatic hydrocarbons. , 1991, Carcinogenesis.

[32]  O. Lockridge,et al.  Reconsideration of the catalytic center and mechanism of mammalian paraoxonase/arylesterase. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[33]  F. A. Smith,et al.  Physiologically based pharmacokinetics and the risk assessment process for methylene chloride. , 1987, Toxicology and applied pharmacology.

[34]  Baggot Jd Application of interspecies scaling to the bispyridinium oxime HI-6. , 1994 .

[35]  S. Packman,et al.  Location of the retinoblastoma susceptibility gene(s) and the human esterase D locus. , 1984, Journal of medical genetics.

[36]  W. Mattes,et al.  alpha-Naphthyl butyrate carboxylesterase activity in human and rat nasal tissue. , 1992, Toxicology and applied pharmacology.

[37]  J R Cashman,et al.  Structural and catalytic properties of the mammalian flavin-containing monooxygenase. , 1995, Chemical research in toxicology.

[38]  P. Coates,et al.  A preliminary genetic interpretation of the esterase isozymes of human tissues , 1975, Annals of human genetics.

[39]  U. Bondesson,et al.  Analysis of methadone disposition in the pregnant rat by means of a physiological flow model , 1985, Journal of Pharmacokinetics and Biopharmaceutics.

[40]  F. Fonnum,et al.  Carboxylesterases, importance for detoxification of organophosphorus anticholinesterases and trichothecenes. , 1985, Fundamental and applied toxicology : official journal of the Society of Toxicology.

[41]  A. Smolen,et al.  PURIFICATION OF HUMAN SERUM PARAOXONASE/ARYLESTERASE , 1991 .

[42]  S. D. Murphy,et al.  The role of hepatic biotransformation in mediating the acute toxicity of the phosphorothionate insecticide chlorpyrifos. , 1984, Toxicology and applied pharmacology.

[43]  D. Hoffmann,et al.  Chemical Studies on Tobacco Smoke LXIV. On the Analysis of Aromatic Amines in Cigarette Smoke , 1979 .

[44]  S. L. Aukerman,et al.  Detoxification of nitrosamides and nitrosocarbamates in blood plasma and tissue homogenates. , 1984, Environmental mutagenesis.

[45]  F. Douglas Boudinot,et al.  Pharmacokinetics of 2′,3′‐Dideoxycytidine in Rats: Application to Interspecies Scale‐up , 1989, The Journal of pharmacy and pharmacology.

[46]  T. Fox,et al.  Molecular mechanisms involved in the toxicity of orthophenylphenol and its sodium salt. , 1983, Chemico-biological interactions.

[47]  E C Miller,et al.  Searches for ultimate chemical carcinogens and their reactions with cellular macromolecules , 1981, Cancer.

[48]  P. Welling,et al.  Pharmacokinetics: Regulatory-Industrial-Academic Perspectives , 1988 .

[49]  M. McKenna,et al.  Hydrolysis of several glycol ether acetates and acrylate esters by nasal mucosal carboxylesterase in vitro. , 1985, Fundamental and applied toxicology : official journal of the Society of Toxicology.

[50]  Antonio F. Hernández,et al.  Differences in the kinetic properties, effect of calcium and sensitivity to inhibitors of paraoxon hydrolase activity in rat plasma and microsomal fraction from rat liver. , 1994, Biochemical pharmacology.

[51]  J. Hearst,et al.  Functional expression of zeaxanthin glucosyltransferase from Erwinia herbicola and a proposed uridine diphosphate binding site. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[52]  K. Krishnaswamy,et al.  Effect of turmeric on xenobiotic metabolising enzymes , 1993, Plant foods for human nutrition.

[53]  K. Bock UDP-glucuronosyltransferases and their role in metabolism and disposition of carcinogens. , 1994, Advances in pharmacology.

[54]  R. Lorentzen,et al.  Benzo[a]yrenedione/benzo[a]pyrenediol oxidation-reduction couples and the generation of reactive reduced molecular oxygen. , 1977, Biochemistry.

[55]  R. Doll,et al.  Etiology of lung cancer. , 1950, Advances in cancer research.

[56]  T. Visser,et al.  Multiple UDP‐glucuronyltransferases for the glucuronidation of thyroid hormone with preference for 3,3',5'‐triiodothyronine (reverse T3) , 1993, FEBS letters.

[57]  J. Yunis,et al.  Retinoblastoma and subband deletion of chromosome 13. , 1978, American journal of diseases of children.

[58]  R. H. Wilson,et al.  The Toxicity and Carcinogenic Activity of 2-Acetaminofluorene , 1941 .

[59]  S. Pond,et al.  Cloning and analysis of a cDNA encoding a human liver carboxylesterase. , 1991, Gene.

[60]  N. Benowitz,et al.  Stereoselective metabolism of (S)-(-)-nicotine in humans: formation of trans-(S)-(-)-nicotine N-1'-oxide. , 1993, Chemical research in toxicology.

[61]  J. Chambers,et al.  Time course of inhibition of acetylcholinesterase and aliesterases following parathion and paraoxon exposures in rats. , 1990, Toxicology and applied pharmacology.

[62]  J. Kuykendall,et al.  Cytotoxicity and DNA-protein crosslink formation in rat nasal tissues exposed to vinyl acetate are carboxylesterase-mediated. , 1993, Toxicology and applied pharmacology.

[63]  F. Kadlubar,et al.  N-methylation: potential mechanism for metabolic activation of carcinogenic primary arylamines. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[64]  K. J. Donham,et al.  Formation and urinary excretion of cyproheptadine glucuronide in monkeys, chimpanzees, and humans. , 1980, Drug metabolism and disposition: the biological fate of chemicals.

[65]  R. E. Reed,et al.  Flavin-containing monooxygenase: a major detoxifying enzyme for the pyrrolizidine alkaloid senecionine in guinea pig tissues. , 1991, Biochemical and biophysical research communications.

[66]  B. Burchell,et al.  The Uridine Diphosphate Glucuronosyltransferase Multigene Family: Function and Regulation , 1994 .

[67]  S. Jezequel Fluconazole: Interspecies Scaling and Allometric Relationships of Pharmacokinetic Properties , 1994, The Journal of pharmacy and pharmacology.

[68]  D. Campbell Can Allometric Interspecies Scaling be Used to Predict Human Kinetics? , 1994 .

[69]  G. Mulder Conjugation reactions in drug metabolism : an integrated approach : substrates, co-substrates, enzymes and their interactions in vivo and in vitro , 1990 .

[70]  T. Lavé,et al.  A new extrapolation method from animals to man: application to a metabolized compound, mofarotene. , 1995, Life sciences.

[71]  C. R. Kee,et al.  Metabolism of dibasic esters by rat nasal mucosal carboxylesterase. , 1991, Drug metabolism and disposition: the biological fate of chemicals.

[72]  F. Fonnum,et al.  Carboxylesterases, Importance for Detoxification of Organophosphorus Anticholinesterases and Trichothecenes , 1985 .

[73]  R Snyder,et al.  Partial hepatectomy reduces both metabolism and toxicity of benzene. , 1979, Journal of toxicology and environmental health.

[74]  N. Benowitz,et al.  Metabolism of nicotine by human liver microsomes: stereoselective formation of trans-nicotine N'-oxide. , 1992, Chemical research in toxicology.

[75]  W. Lee,et al.  Purification, biochemical characterization, and biological function of human esterase D. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[76]  A. Pandey,et al.  Effect of UDP-glucuronyltransferase induction on zearalenone metabolism. , 1990, Toxicology letters.

[77]  M. Castle,et al.  Species differences in the hydrolysis of meperidine and its inhibition by organophosphate compounds. , 1988, Fundamental and applied toxicology : official journal of the Society of Toxicology.

[78]  A. Smolen,et al.  Purification of human serum paraoxonase/arylesterase. Evidence for one esterase catalyzing both activities. , 1991, Drug metabolism and disposition: the biological fate of chemicals.

[79]  N. Schiller,et al.  Malathion and phenthoate carboxylesterase activities in pulmonary alveolar macrophages as indicators of lung injury. , 1983, Toxicology and applied pharmacology.

[80]  P. Magee,et al.  Interspecies scaling of the pharmacokinetics of N-nitrosodimethylamine. , 1990, Cancer research.

[81]  J. Miller,et al.  Hepatic microsomal N-glucuronidation and nucleic acid binding of N-hydroxy arylamines in relation to urinary bladder carcinogenesis. , 1977, Cancer research.

[82]  M. Ehrich,et al.  DDVP (dichlorvos) detoxification by binding and interactions with DDT, dieldrin, and malaoxon. , 1977, Journal of toxicology and environmental health.

[83]  H. Boxenbaum,et al.  Physiological Models, Allometry, Neoteny, Space-Time and Pharmacokinetics , 1988 .

[84]  D. M. Maxwell,et al.  The effect of carboxylesterase inhibition on interspecies differences in soman toxicity. , 1987, Toxicology letters.

[85]  M. Tsuboi,et al.  Comparative study of human intestinal and hepatic esterases as related to enzymatic properties and hydrolizing activity for ester-type drugs. , 1980, Japanese journal of pharmacology.

[86]  H. Boxenbaum,et al.  Interspecies pharmacokinetic scaling and the Dedrick plots. , 1983, The American journal of physiology.

[87]  C. Green,et al.  Effects of soya bean flakes and liquorice root extract on enzyme induction and toxicity in B6C3F1 mice. , 1993, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[88]  S. Mommsen,et al.  Tobacco as a risk factor in bladder cancer. , 1983, Carcinogenesis.

[89]  W. J. Meek,et al.  THE FEDERATION OF AMERICAN SOCIETIES FOR EXPERIMENTAL BIOLOGY. , 1938, Science.

[90]  J. Miller,et al.  Electrophilic sulfuric acid ester metabolites as ultimate carcinogens. , 1986, Advances in experimental medicine and biology.

[91]  Z. Radić,et al.  Differentiation of esterases reacting with organophosphorus compounds. , 1993, Chemico-biological interactions.

[92]  F. Fonnum,et al.  Metabolism of T-2 toxin by rat liver carboxylesterase. , 1986, Biochemical pharmacology.

[93]  L. Sultatos,et al.  The role of calcium in the hydrolysis of the organophosphate paraoxon by human serum A-esterase. , 1995, Life sciences.

[94]  E. Heymann,et al.  Organophosphate sensitive and insensitive carboxylesterases in human skin. , 1993, Chemico-biological interactions.

[95]  T. Ma,et al.  Role of detoxication pathways in acute toxicity levels of phosphorothionate insecticides in the rat. , 1994, Life sciences.

[96]  P. Bosma,et al.  Jaundice and disorders of bilirubin metabolism , 1998 .

[97]  T. Omura,et al.  Molecular cloning and characterization of a human carboxylesterase gene. , 1993, Genomics.

[98]  K. Bischoff,et al.  Interspecies correlation of plasma concentration history of methotrexate (NSC-740). , 1970, Cancer chemotherapy reports.

[99]  D. Lang,et al.  Structural requirements for the inhibition of human monocyte carboxylesterase by organophosphorus compounds. , 1991, Chemico-biological interactions.

[100]  V. Jagadeesan,et al.  Effect of long term iron deficiency on the activities of hepatic and extra-hepatic drug metabolising enzymes in Fischer rats. , 1995, Comparative biochemistry and physiology. Part B, Biochemistry & molecular biology.

[101]  Cornelius Ce Fasting hyperbilirubinemia in Bolivian squirrel monkeys with a Gilbert's-like syndrome. , 1993 .

[102]  G. E. Smith The Human Brain , 1924, Nature.

[103]  B. Burchell,et al.  Glucuronidation in fish , 1991 .

[104]  W. Bosron,et al.  Purification and characterization of a human liver cocaine carboxylesterase that catalyzes the production of benzoylecgonine and the formation of cocaethylene from alcohol and cocaine. , 1994, Biochemical pharmacology.

[105]  A. Smolen,et al.  Characteristics of the genetically determined allozymic forms of human serum paraoxonase/arylesterase. , 1991, Drug metabolism and disposition: the biological fate of chemicals.

[106]  Malcolm Rowland,et al.  Clinical pharmacokinetics : concepts and applications , 1989 .

[107]  R. Gupta,et al.  Concerted role of carboxylesterases in the potentiation of carbofuran toxicity by iso-OMPA pretreatment. , 1989, Journal of toxicology and environmental health.

[108]  F. Chu,et al.  Modification of in vitro metabolism of T-2 toxin by esterase inhibitors , 1985, Applied and environmental microbiology.

[109]  A. Viani,et al.  Human Brain Sulphotransferase and Glucuronyltransferase , 1990, Human & experimental toxicology.

[110]  Sam Smoking-attributable mortality and years of potential life lost--United States, 1988. , 1991, MMWR. Morbidity and mortality weekly report.

[111]  P. Blain,et al.  Human xenobiotic metabolizing esterases in liver and blood. , 1993, Biochemical pharmacology.

[112]  J. Crigler,et al.  Congenital familial nonhemolytic jaundice with kernicterus. , 1952, Pediatrics.

[113]  C. Fenselau,et al.  Species-dependent glucuronidation of drugs by immobilized rabbit, rhesus monkey, and human UDP-glucuronyltransferases. , 1987, Drug metabolism and disposition: the biological fate of chemicals.

[114]  Y. Fujii‐Kuriyama,et al.  Cloning and characterization of cDNA encoding 3-methylcholanthrene inducible rat mRNA for UDP-glucuronosyltransferase. , 1986, The Journal of biological chemistry.

[115]  F. Williams Clinical Significance of Esterases in Man , 1985, Clinical pharmacokinetics.